Aditxt, Inc. Files 8-K Report
Ticker: ADTX · Form: 8-K · Filed: Mar 24, 2025 · CIK: 1726711
Sentiment: neutral
Topics: 8-K, financial-statements, exhibits
TL;DR
Aditxt filed an 8-K, mostly financial docs, no major news.
AI Summary
On March 21, 2025, Aditxt, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, with no specific material events or disclosures detailed in the provided text. The company, formerly known as Aditx Therapeutics, Inc., is incorporated in Delaware and operates in the Pharmaceutical Preparations sector.
Why It Matters
This 8-K filing indicates Aditxt, Inc. is fulfilling its reporting obligations with the SEC, primarily related to financial statements and exhibits.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for financial statements and exhibits, not indicating any immediate material changes or risks.
Key Players & Entities
- Aditxt, Inc. (company) — Registrant
- Aditx Therapeutics, Inc. (company) — Former company name
- 20250321 (date) — Date of earliest event reported
- 20250324 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- PHARMACEUTICAL PREPARATIONS [2834] (industry) — Standard Industrial Classification
FAQ
What is the primary purpose of this 8-K filing for Aditxt, Inc.?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of March 21, 2025.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on March 21, 2025.
What is Aditxt, Inc.'s state of incorporation?
Aditxt, Inc. is incorporated in Delaware.
What was Aditxt, Inc.'s former company name?
Aditxt, Inc.'s former company name was Aditx Therapeutics, Inc.
What is Aditxt, Inc.'s Standard Industrial Classification code?
Aditxt, Inc.'s Standard Industrial Classification code is 2834, for Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 24, 2025 regarding Aditxt, Inc. (ADTX).